U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07295717) titled 'A Study to Evaluate ALN-4285 in Adult Healthy Volunteers' on Dec. 10.
Brief Summary: The purpose of this study is to:
* evaluate the safety and tolerability of single ascending doses of ALN-4285 in healthy volunteers
* characterize the single-dose pharmacokinetics (PK) of ALN-4285
Study Start Date: Dec. 12
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ALN-4285
ALN-4285 will be administered SC
DRUG: Placebo
Placebo will be administered SC
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Alnylam Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest...